PubMed · 12702003
Repaglinide at a cellular level.
Abstract
To investigate the hormonal and cellular selectivity of the prandial glucose regulators, we have undertaken a series of experiments, in which we characterised the effects of repaglinide and nateglinide on ATP-sensitive potassium ion (KATP) channel activity, membrane potential and exocytosis in rat pancreatic alpha-cells and somatotrophs. We found a pharmacological dissociation between the actions on KATP channels and exocytosis and suggest that compounds that, unlike repaglinide, have direct stimulatory effects on exocytosis in somatotrophs and alpha- and beta-cells, such as sulphonylureas and nateglinide, may have a clinically undesirable general stimulatory effect on cells within the endocrine system.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
M Krogsgaard Thomsen, K Bokvist, M Høy, K Buschard, J J Holst, P Lindström, J Gromada. 2002. Repaglinide at a cellular level.. https://pubmed.health/record/pubmed%3A12702003/repaglinide-at-a-cellular-level
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.